Financings
Elixxer Announces Results of Annual and Special Meeting of Shareholders
ELXR · Price
Executive Summary
- Elixxer Ltd. held its annual and special shareholders’ meeting on December 30 2025, approving a slate of corporate actions by overwhelming majorities.
- Shareholders elected four new directors, re‑appointed auditors (CAN Partners LLP), approved a name‑change resolution, and authorized a 90‑to‑1 share consolidation.
- A voluntary delisting from the TSX Venture Exchange was approved, representing a material negative development for the company’s public‑market status.
Key Details
- Directors elected: Jayahari Balasubramaniam, Alexey (Alex) Kanayev, Mark E. Romano, Edward Milewski – each received 98.99% votes in favour.
- Auditor appointment: CAN Partners LLP approved with 99.06% of votes cast.
- Name‑change resolution: Approved 99.00% (3,760,311 votes) to allow the Board to change the corporate name under the Canada Business Corporations Act.
- Share consolidation: Special resolution for a 90 pre‑consolidation shares → 1 post‑consolidation share approved 98.86% (3,754,823 votes).
- Stock Option Plan re‑approval: Passed with 98.99% support (3,756,098 votes).
- Debt settlement authority: Shareholders authorized issuance of common shares to settle indebtedness – approved 75.01% (123,627 votes).
- Voluntary delisting from TSXV: Approved by a “majority of the minority” of disinterested shareholders – 69.13% in favour (113,932 votes) versus 30.87% against.
Notable Quotes
- “We appreciate the continued support of our shareholders as we take these strategic steps to streamline our capital structure and transition away from the TSX Venture Exchange,” — Karim Mecklai, Chief Executive Officer.